![global 7 diagnostics global 7 diagnostics](https://image.slidesharecdn.com/globalin-vitrodiagnosticsivdmarketreport-151215161538/95/global-invitro-diagnostics-ivd-market-report-2015-edition-new-report-by-koncept-analytics-6-638.jpg)
Healthcare providers and vendors are actively engaged in providing an expedited diagnosis of HAIs for quick clinical decision-making to support treatment regimens. There is a widespread concern of adverse effects of hospital-acquired infections (HAIs), which are increasing the market share of the Healthcare-associated Infections Diagnostics Market. Kits that allow simultaneous determination of both HIV-specific antibodies and the p24 antigen have been recently introduced, thereby increasing the demand. Conventional methods for HIV testing, based on the detection of HIV-specific antibodies, have been improved over time, gaining in sensitivity and specificity.
#Global 7 diagnostics driver#
Improvements and enhancements in infectious disease testing methods for HIV testing and sexually transmitted disease is a major driver for the segment growth. The presence of a high pool of infected patients who are undiagnosed and need urgent diagnosis is another driver influencing the segment growth. The staggering rise in liver damage cases due to viral infections, drug, and chemical abuses, and an increase in alcohol intake, is contributing to the growth of the segment. The hepatitis segment is likely to grow at a CAGR of over 4% during the period 2019–2025. Therefore, the increasing burden of TB disease across the world, especially in India, China, South Africa, and Bangladesh constituting a significant percentage of TB cases, is likely to influence the segment growth. By the end of 2018, around 10 million people were infected with TB, including 5.7 million men, 3.2 million women, and 1.1 million children. Tuberculosis (TB) segment is expected to be one of the major revenue contributors by 2025.
![global 7 diagnostics global 7 diagnostics](https://www.prlog.org/12661221-india-ivd-market-infographic.png)
However, these tests are comparatively complicated and expensive. They have comparatively higher sensitivity and specificity than immunoassays. Molecular diagnostic tests are based on DNA amplification techniques. However, the infectious disease molecular diagnostics market is rapidly capturing the revenue share of the traditional segment. Conventional diagnostics include immunodiagnostics, blood culture tests, and clinical, microbiological methods to diagnose several diseases. The segment is growing at a moderate rate than molecular diagnostics. In 2019, the traditional diagnostics segment accounted for 66% of the infectious disease diagnostics market share. This research report includes a detailed segmentation by GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION The infectious disease diagnostics market in India is likely to grow at a CAGR of over 8% during the period 2019–2025 on account of the rapidly growing patient pool with infectious diseases and increased market access.The standard reference laboratories segment is projected to over $8 billion by 2025, owing to the rise of private laboratories, especially in developing countries.The consumable segment is likely to observe an incremental growth of over $7 billion by 2025 on account of the increasing sale of high-end instruments by hospitals, commercial labs, and other facilities.
![global 7 diagnostics global 7 diagnostics](https://i.ytimg.com/vi/B9vKWUJrINs/maxresdefault.jpg)
The usage of diagnostic techniques to diagnose several HAIs is considered as an important step to initiate several preventive measures.